Inter-Tissue Gene Co-Expression Networks between Metabolically Healthy and Unhealthy Obese Individuals

Lisette J A Kogelman, Jingyuan Fu, Lude Franke, Jan Willem Greve, Marten Hofker, Sander S Rensen, Haja N Kadarmideen, Lisette J A Kogelman, Jingyuan Fu, Lude Franke, Jan Willem Greve, Marten Hofker, Sander S Rensen, Haja N Kadarmideen

Abstract

Background: Obesity is associated with severe co-morbidities such as type 2 diabetes and nonalcoholic steatohepatitis. However, studies have shown that 10-25 percent of the severely obese individuals are metabolically healthy. To date, the identification of genetic factors underlying the metabolically healthy obese (MHO) state is limited. Systems genetics approaches have led to the identification of genes and pathways in complex diseases. Here, we have used such approaches across tissues to detect genes and pathways involved in obesity-induced disease development.

Methods: Expression data of 60 severely obese individuals was accessible, of which 28 individuals were MHO and 32 were metabolically unhealthy obese (MUO). A whole genome expression profile of four tissues was available: liver, muscle, subcutaneous adipose tissue and visceral adipose tissue. Using insulin-related genes, we used the weighted gene co-expression network analysis (WGCNA) method to build within- and inter-tissue gene networks. We identified genes that were differentially connected between MHO and MUO individuals, which were further investigated by homing in on the modules they were active in. To identify potentially causal genes, we integrated genomic and transcriptomic data using an eQTL mapping approach.

Results: Both IL-6 and IL1B were identified as highly differentially co-expressed genes across tissues between MHO and MUO individuals, showing their potential role in obesity-induced disease development. WGCNA showed that those genes were clustering together within tissues, and further analysis showed different co-expression patterns between MHO and MUO subnetworks. A potential causal role for metabolic differences under similar obesity state was detected for PTPRE, IL-6R and SLC6A5.

Conclusions: We used a novel integrative approach by integration of co-expression networks across tissues to elucidate genetic factors related to obesity-induced metabolic disease development. The identified genes and their interactions give more insight into the genetic architecture of obesity and the association with co-morbidities.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. The adjacency matrix to construct…
Fig 1. The adjacency matrix to construct the within- and inter-tissue gene network.
The matrix presents the adjacency for L = Liver, M = Muscle, S = Subcutaneous Adipose Tissue, V = Vat, for i till n genes. In red the within-tissue blocks, in black the inter-tissue blocks.
Fig 2. Network visualization of inter-tissue network…
Fig 2. Network visualization of inter-tissue network modules.
Visualization of the genes in the (A) Greenyellow module (from MUO subnetwork) in the MHO and MUO individuals, and (B) Turquoise module (from MUO subnetwork) in the MHO and MUO individuals. Genes coming from liver are coloured yellow, from muscle orange, from VAT blue and from SAT green. IL1B and IL-6 are bordered red. Edges are coloured based on their correlation on a red-green scale representing a negative-positive correlation.
Fig 3. Network visualization of the inter-tissue…
Fig 3. Network visualization of the inter-tissue network modules.
Visualization of the genes in the (A) Black module (from MUO subnetwork) in the MHO and MUO individuals, and (B) Salmon module (from MUO subnetwork) in the MHO and MUO individuals. Genes coming from liver are coloured yellow, from muscle orange, from VAT blue and from SAT green. IL1B and IL-6 are bordered red. Edges are coloured based on their correlation on a red-green scale representing a negative-positive correlation.

References

    1. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Current opinion in lipidology. 2010;21:38–43. 10.1097/MOL.0b013e3283346ccc
    1. Lavie CJ, De Schutter A, Milani RV. Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol. 2015;11(1):55–62. 10.1038/nrendo.2014.165
    1. Salans LB, Knittle JL, Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest. 1968;47(1):153–65. 10.1172/JCI105705
    1. Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C, et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes. 2005;54(6):1706–16.
    1. Slawik M, Vidal-Puig AJ. Adipose tissue expandability and the metabolic syndrome. Genes & Nutrition. 2007;2(1):41–5.
    1. Eldor R, Raz I. Lipotoxicity versus adipotoxicity—The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes. Diabetes Research and Clinical Practice. 2006;74(2, Supplement):S3–S8.
    1. Samdani P, Singhal M, Sinha N, Tripathi P, Sharma S, Tikoo K, et al. A Comprehensive Inter-Tissue Crosstalk Analysis Underlying Progression and Control of Obesity and Diabetes. Scientific Reports. 2015;5:12340 10.1038/srep12340
    1. Rousso-Noori L, Knobler H, Levy-Apter E, Kuperman Y, Neufeld-Cohen A, Keshet Y, et al. Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner. Cell Metab. 2011;13(5):562–72. 10.1016/j.cmet.2011.02.017
    1. Argiles JM, Lopez-Soriano J, Almendro V, Busquets S, Lopez-Soriano FJ. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Medicinal research reviews. 2005;25(1):49–65. 10.1002/med.20010
    1. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.
    1. Min JL, Nicholson G, Halgrimsdottir I, Almstrup K, Petri A, Barrett A, et al. Coexpression Network Analysis in Abdominal and Gluteal Adipose Tissue Reveals Regulatory Genetic Loci for Metabolic Syndrome and Related Phenotypes. PLoS Genetics. 2012;8(2):e1002505 10.1371/journal.pgen.1002505
    1. Dewey FE, Perez MV, Wheeler MT, Watt C, Spin J, Langfelder P, et al. Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circulation Cardiovascular genetics. 2011;4(1):26–35. 10.1161/CIRCGENETICS.110.941757
    1. de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One. 2012;7(6):e39498 10.1371/journal.pone.0039498
    1. Kogelman LJA, Cirera S, Zhernakova D, Fredholm M, Franke L, Kadarmideen H. Identification of co-expression gene networks, regulatory genes and pathways for obesity based on adipose tissue RNA Sequencing in a porcine model. BMC Med Genomics. 2014;7(1):57.
    1. Talukdar Husain A, Foroughi Asl H, Jain Rajeev K, Ermel R, Ruusalepp A, Franzén O, et al. Cross-Tissue Regulatory Gene Networks in Coronary Artery Disease. Cell Systems. 2016;2:196–208. 10.1016/j.cels.2016.02.002
    1. Fu J, Wolfs MGM, Deelen P, Westra H-J, Fehrmann RSN, te Meerman GJ, et al. Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression. PLoS Genet. 2012;8(1):e1002431 10.1371/journal.pgen.1002431
    1. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ, et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet. 2011;7(8):e1002197 10.1371/journal.pgen.1002197
    1. Wolfs M, Rensen S, Bruin-Van Dijk E, Verdam F, Greve J-W, Sanjabi B, et al. Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genomics. 2010;3(1):34.
    1. Bonder MJ, Kasela S, Kals M, Tamm R, Lokk K, Barragan I, et al. Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics. 2014;15:860 10.1186/1471-2164-15-860
    1. Haider S, Ballester B, Smedley D, Zhang J, Rice P, Kasprzyk A. BioMart Central Portal—unified access to biological data. Nucleic Acids Research. 2009;37(suppl 2):W23–W7.
    1. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24(5):719–20. 10.1093/bioinformatics/btm563
    1. Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nature Genetics. 2013;45(10):1238–43. 10.1038/ng.2756
    1. Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504. 10.1101/gr.1239303
    1. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC endocrine disorders. 2014;14:9 10.1186/1472-6823-14-9
    1. Dobrin R, Zhu J, Molony C, Argman C, Parrish ML, Carlson S, et al. Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biology. 2009;10(R55).
    1. Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante A. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808. 10.1172/JCI19246
    1. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology. 2007;148(1):241–51. 10.1210/en.2006-0692
    1. Mojtaba E, Mahdi K. Serum interleukin-1 beta plays an important role in insulin secretion in type II diabetic. International Journal of Biosciences. 2011;1(3):93–9.
    1. Bing C. Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity? Adipocyte. 2015;4(2):149–52. 10.4161/21623945.2014.979661
    1. Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, et al. Interleukin-1β Regulates Fat-Liver Crosstalk in Obesity by Auto-Paracrine Modulation of Adipose Tissue Inflammation and Expandability. PLoS ONE. 2013;8(1):e53626 10.1371/journal.pone.0053626
    1. Ahl S, Guenther M, Zhao S, James R, Marks J, Szabo A, et al. Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals. The Journal of clinical endocrinology and metabolism. 2015;100(11):4172–80. 10.1210/jc.2015-2765
    1. Marques-Vidal P, Velho S, Waterworth D, Waeber G, von Kanel R, Vollenweider P. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used. European journal of clinical nutrition. 2012;66(4):426–35. 10.1038/ejcn.2011.170
    1. Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, et al. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun. 2003;310(2):550–4.
    1. Schobitz B, Pezeshki G, Pohl T, Hemmann U, Heinrich PC, Holsboer F, et al. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1995;9(8):659–64.
    1. Fornes A, Nunez E, Alonso-Torres P, Aragon C, Lopez-Corcuera B. Trafficking properties and activity regulation of the neuronal glycine transporter GLYT2 by protein kinase C. Biochem J. 2008;412(3):495–506. 10.1042/BJ20071018
    1. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52(3):812–7.
    1. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. 10.1038/nprot.2008.211
    1. Wunderlich CM, Hovelmeyer N, Wunderlich FT. Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. Jak-stat. 2013;2(2):e23878 10.4161/jkst.23878
    1. Olson AL. Insulin resistance: cross-talk between adipose tissue and skeletal muscle, through free fatty acids, liver X receptor, and peroxisome proliferator-activated receptor-alpha signaling. Hormone molecular biology and clinical investigation. 2013;15(3):115–21. 10.1515/hmbci-2013-0019
    1. Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448–57. 10.1038/ni.3153
    1. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Current opinion in lipidology. 2010;21(1):38–43. 10.1097/MOL.0b013e3283346ccc
    1. Min JL, Nicholson G, Halgrimsdottir I, Almstrup K, Petri A, Barrett A, et al. Coexpression Network Analysis in Abdominal and Gluteal Adipose Tissue Reveals Regulatory Genetic Loci for Metabolic Syndrome and Related Phenotypes. PLoS Genet. 2012;8(2):e1002505 10.1371/journal.pgen.1002505
    1. Kosicka A, Cunliffe AD, Mackenzie R, Zariwala MG, Perretti M, Flower RJ, et al. Attenuation of plasma annexin A1 in human obesity. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2013;27(1):368–78.
    1. John C, Cover P, Solito E, Morris J, Christian H, Flower R, et al. Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology. 2002;143(8):3060–70. 10.1210/endo.143.8.8965
    1. Wallerstedt E, Smith U, Andersson CX. Protein kinase C-delta is involved in the inflammatory effect of IL-6 in mouse adipose cells. Diabetologia. 2010;53(5):946–54. 10.1007/s00125-010-1668-1
    1. Bogdanik LP, Chapman HD, Miers KE, Serreze DV, Burgess RW. A MusD Retrotransposon Insertion in the Mouse Slc6a5 Gene Causes Alterations in Neuromuscular Junction Maturation and Behavioral Phenotypes. PLoS ONE. 2012;7(1):e30217 10.1371/journal.pone.0030217
    1. Aga-Mizrachi S, Brutman-Barazani T, Jacob AI, Bak A, Elson A, Sampson SR. Cytosolic protein tyrosine phosphatase-epsilon is a negative regulator of insulin signaling in skeletal muscle. Endocrinology. 2008;149(2):605–14. 10.1210/en.2007-0908
    1. Beretta M, Bauer M, Hirsch E. PI3K signaling in the pathogenesis of obesity: The cause and the cure. Advances in biological regulation. 2015;58:1–15. 10.1016/j.jbior.2014.11.004
    1. Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert reviews in molecular medicine. 2012;14:e1 10.1017/S1462399411002109
    1. Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, et al. Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action. Cell Metabolism. 2010;12(3):237–49. 10.1016/j.cmet.2010.06.011
    1. Greenawalt DM, Dobrin R, Chudin E, Hatoum IJ, Suver C, Beaulaurier J, et al. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Research. 2011;21(7):1008–16. 10.1101/gr.112821.110
    1. Ahrens M, Ammerpohl O, von Schönfels W, Kolarova J, Bens S, Itzel T, et al. DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery. Cell Metabolism. 2013;18(2):296–302. 10.1016/j.cmet.2013.07.004

Source: PubMed

3
購読する